For the Inventor, By the Inventor

Enter assignee name

Daegu, South Korea

Daegu-Gyeongbuk Medical Innovation Foundation

USPTO Granted Patents = 8

EPO Patents = 7

Forward Citations = 7

Loading Chart...

Loading Chart...

77 inventors (with patents filed for the assignee):

So Young Kim (5 out of 41 patents)

Hwan Geun Choi (4 out of 51 patents)

Jung Beom Son (4 out of 16 patents)

4. Yi Kyung Ko (4 out of 8 patents)

5. Seungyeon Lee (4 out of 6 patents)

6. Nam Doo Kim (4 out of 10 patents)

7. Seock Yong Kang (4 out of 5 patents)

8. Eunhwa Ko (3 out of 4 patents)

9. Jin-Hee Park (3 out of 4 patents)

10. Sun-Hwa Lee (3 out of 4 patents)

11. Dayea Kim (3 out of 3 patents)

12. Sun Joo Lee (3 out of 3 patents)

13. Jae Hyun Bae (3 out of 3 patents)

14. Sang Bum Kim (3 out of 151 patents)

15. In-Kyu Lee (2 out of 5 patents)

8 patents: Sort by Forward Citations

1. 12502434 - Compound comprising EZH2 inhibitor and E3 ligase binder and pharmaceutical composition for preventing or treating EZH2-associated disease comprising same as active ingredient (2025-12-23),

2. 12285401 - Pharmaceutical composition comprising trimebutine or pharmaceutically acceptable salt thereof as an active ingredient for prevention or treatment of cancer (2025-04-29),

3. 11285226 - Aryl ethene derivative and pharmaceutical composition containing same as active ingredient (2022-03-29),

4. 11208412 - Pyrrolo-pyrimidine derivative compound, preparation method therefor, and pharmaceutical composition comprising same compound as effective ingredient for preventing or treating protein kinase-related disease (2021-12-28),

5. 11117892 - Pyrrolo-pyridine derivative compound, method for preparing same, and pharmaceutical composition containing same as active ingredient for prevention or treatment of protein kinase-related diseases (2021-09-14),

6. 10934303 - Aryl ethene derivative and pharmaceutical composition containing same as active ingredient (2021-03-02),

7. 10870647 - Imidazopyridine derivative, method for preparing same, and pharmaceutical composition containing same as active ingredient for preventing or treating cancer (2020-12-22),

8. 10442796 - 2,3,5-substituted thiophene compound as protein kinase inhibitor (2019-10-15),

Daegu-gyeongbuk Medical Innovation Foundation (DGMIF) is a non-profit organization dedicated to promoting medical innovation and scientific research in the Daegu and Gyeongbuk regions of South Korea. Established in 2000, DGMIF provides support for medical startups, research projects, and training programs to advance healthcare technologies and improve patient care.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

8 Patents

#21 in Daegu 706-010

#1,249 in South Korea

Daegu, South Korea

Daegu-Gyeongbuk Medical Innovation Foundation

Forward Citations = 7

77 inventors:

So Young Kim (5 out of 41 patents)

Hwan Geun Choi (4 out of 51 patents)

Jung Beom Son (4 out of 16 patents)

4. Yi Kyung Ko (4 out of 8 patents)

5. Seungyeon Lee (4 out of 6 patents)

Please report any incorrect information to support@idiyas.com

Loading…